KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non-Current Debt: 2010-2025

Historic Non-Current Debt for Jazz Pharmaceuticals (JAZZ) over the last 14 years, with Sep 2025 value amounting to $4.3 billion.

  • Jazz Pharmaceuticals' Non-Current Debt fell 28.76% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year decrease of 28.76%. This contributed to the annual value of $6.1 billion for FY2024, which is 18.98% up from last year.
  • Jazz Pharmaceuticals' Non-Current Debt amounted to $4.3 billion in Q3 2025, which was down 0.08% from $4.3 billion recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Non-Current Debt ranged from a high of $6.5 billion in Q2 2021 and a low of $1.9 billion during Q1 2021.
  • Moreover, its 3-year median value for Non-Current Debt was $5.1 billion (2023), whereas its average is $5.3 billion.
  • In the last 5 years, Jazz Pharmaceuticals' Non-Current Debt soared by 238.85% in 2021 and then dropped by 28.76% in 2025.
  • Quarterly analysis of 5 years shows Jazz Pharmaceuticals' Non-Current Debt stood at $6.0 billion in 2021, then declined by 5.41% to $5.7 billion in 2022, then dropped by 10.28% to $5.1 billion in 2023, then rose by 18.98% to $6.1 billion in 2024, then declined by 28.76% to $4.3 billion in 2025.
  • Its Non-Current Debt was $4.3 billion in Q3 2025, compared to $4.3 billion in Q2 2025 and $5.3 billion in Q1 2025.